4.4 Review

Buccal Dosage Forms: General Considerations for Pediatric Patients

Journal

AAPS PHARMSCITECH
Volume 18, Issue 2, Pages 273-282

Publisher

SPRINGER
DOI: 10.1208/s12249-016-0567-2

Keywords

buccal delivery; mucoadhesion; pediatric dosage forms; pediatric films; pediatric tablets; transmucosal

Funding

  1. STINT project [IB2015-6087]
  2. FONDECYT [11130235]
  3. FONDAP [15130011]

Ask authors/readers for more resources

The development of an appropriate dosage form for pediatric patients needs to take into account several aspects, since adult drug biodistribution differs from that of pediatrics. In recent years, buccal administration has become an attractive route, having different dosage forms under development including tablets, lozenges, films, and solutions among others. Furthermore, the buccal epithelium can allow quick access to systemic circulation, which could be used for a rapid onset of action. For pediatric patients, dosage forms to be placed in the oral cavity have higher requirements for palatability to increase acceptance and therapy compliance. Therefore, an understanding of the excipients required and their functions and properties needs to be particularly addressed. This review is focused on the differences and requirements relevant to buccal administration for pediatric patients (compared to adults) and how novel dosage forms can be less invasive and more acceptable alternatives.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available